Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

Arimoclomol to treat neurological disease manifestation of Niemann-Pick disease type C

Laufzeit: 01.01.2016 - 31.12.2018

Kurzfassung


A)A retrospective, non-interventional study of the data of patients diagnosed with Niemann-Pick disease type C in order to confirm ASIS as a disease progression predictive model/tool
B) A prospective non-therapeutic study in patients diagnosed with Niemann-Pick disease type C in order to characterise the individual patient disease profile and historic signo-symptomatology progression pattern
C) Arimoclomol prospective double-blind, randomised, placebo-controlled study in patients diagnosed with...
A)  A retrospective, non-interventional study of the data of patients diagnosed with Niemann-Pick disease type C in order to confirm ASIS as a disease progression predictive model/tool
B) A prospective non-therapeutic study in patients diagnosed with Niemann-Pick disease type C in order to characterise the individual patient disease profile and historic signo-symptomatology progression pattern 
C) Arimoclomol prospective double-blind, randomised, placebo-controlled study in patients diagnosed with Niemann-Pick disease type C
» weiterlesen» einklappen

Beteiligte Einrichtungen